Insider · CIK 0001870373
Samuel Whiting
Files at TPST (Tempest Therapeutics, Inc.). First filing -, latest -.
In brief
Samuel Whiting files SEC Form 4 as officer at TPST (Tempest Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Samuel Whiting has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 11, 2023 | TPST Tempest Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +325,000 | $0.00 | $0 | 325,000 | Oct 13, 2023 |
Questions about Samuel Whiting
Answered from the filings on this page, as of the latest one.
Is Samuel Whiting buying or selling?
Samuel Whiting has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Samuel Whiting's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Samuel Whiting has 0.
Where does Samuel Whiting file Form 4?
Samuel Whiting has filed Form 4 at TPST (Tempest Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.